Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, USA.
Ear Hear. 2022;43(4):1282-1290. doi: 10.1097/AUD.0000000000001176. Epub 2021 Nov 30.
This study identified an association between cholesteatoma and progressive sensorineural hearing loss using a large pediatric longitudinal audiologic dataset. Cholesteatoma is a potential sequela of chronic otitis media with effusion, a commonly observed auditory pathology that can contribute to hearing loss in children. The purpose of this report is to (i) describe the process of identifying the association between cholesteatoma and progressive sensorineural hearing loss in a large pediatric dataset and (ii) describe the audiologic data acquired over time in patients identified with cholesteatoma-associated progressive sensorineural hearing loss.
Records of patients included in the Audiologic and Genetics Database (n = 175,215 patients) were examined using specified criteria defining progressive hearing loss. A linear regression model examined the log frequency of all diagnostic codes in the electronic health record assigned to patients for a progressive hearing loss cohort compared with a stable hearing loss group. Based on findings from the linear regression analysis, longitudinal audiometric air (AC) and bone conduction (BC) thresholds were extracted for groups of subjects with cholesteatoma-associated progressive (n = 58 subjects) and stable (n = 55 subjects) hearing loss to further analyze changes in hearing over time.
The linear regression analyses identified that diagnostic codes for cholesteatoma were associated with progressive sensorineural hearing loss in children. The longitudinal audiometric data demonstrated within-subject changes in masked BC sensitivity consistent with progressive sensorineural hearing loss in children diagnosed with cholesteatoma. Additional analyses showed that mastoidectomy surgeries did not appear to contribute to the observed progressive hearing loss and that a high number of cholesteatoma patients with progressive hearing loss had normal-hearing thresholds at their first test.
The statistical analyses demonstrated an association between cholesteatoma and pediatric progressive sensorineural hearing loss. These findings inform clinical management by suggesting that children with cholesteatoma diagnoses may be at increased risk for progressive sensorineural hearing loss and should receive continued monitoring even after a normal masked BC baseline has been established.
本研究使用大型儿科纵向听力数据集确定胆脂瘤与进行性感音神经性听力损失之间的关联。胆脂瘤是慢性分泌性中耳炎的潜在后遗症,是一种常见的听觉病理学,可导致儿童听力损失。本报告的目的是:(i)描述在大型儿科数据集中识别胆脂瘤与进行性感音神经性听力损失之间关联的过程;(ii)描述在诊断为胆脂瘤相关进行性感音神经性听力损失的患者中随时间获得的听力数据。
使用定义进行性听力损失的特定标准检查包含在听力和遗传学数据库(n = 175,215 例患者)中的患者记录。线性回归模型检查了电子健康记录中分配给进行性听力损失队列患者的所有诊断代码的对数频率,与稳定听力损失组进行比较。基于线性回归分析的结果,为具有胆脂瘤相关进行性(n = 58 例)和稳定(n = 55 例)听力损失的受试者组提取了纵向听力空气(AC)和骨传导(BC)阈值,以进一步分析随时间的听力变化。
线性回归分析确定胆脂瘤的诊断代码与儿童进行性感音神经性听力损失相关。纵向听力数据显示,与诊断为胆脂瘤的儿童进行性感音神经性听力损失一致的受试者内掩蔽 BC 敏感性变化。进一步的分析表明,乳突切除术似乎并未导致观察到的进行性听力损失,并且许多患有进行性听力损失的胆脂瘤患者在首次检查时听力阈值正常。
统计分析表明胆脂瘤与儿科进行性感音神经性听力损失之间存在关联。这些发现通过提示患有胆脂瘤诊断的儿童可能患有进行性感音神经性听力损失的风险增加,并且即使在建立正常掩蔽 BC 基线后,也应继续监测,为临床管理提供信息。